What we learned from J.P. Morgan Healthcare Conference 2017

Rumblings of imminent healthcare policy changes were not enough to distract attendees at this year’s J.P. Morgan Healthcare Conference 2017 from their focus on several key themes at this year’s event.  Below is a list of our key takeaways from what remains one of the most significant annual healthcare business conferences. The drive to value… read more

We Honor our pharmacists on National Pharmacist Day

In honor of National Pharmacist Day on January 12, we would like to take this time to honor the pharmacists that dedicate themselves to serving and helping our patients improve their health outcomes and lives. We greatly appreciate our pharmacists and the fact that they continually act and build upon our vision and belief in… read more

What do you need to know about the 21st Century Cures Act?

It will add new tools to the life science toolbox. More patients may begin to receive more medical products than before, due to the fact that the Act includes numerous provisions meant to speed up the approval process for new drugs and devices. It supports evolution of the FDA approval process. “The bill allows for… read more

How to unlock a $41 billion pharmaceutical revenue opportunity

From 2012-2015 there was a 13% increase in pharmaceutical revenue loss amounting to an estimated $637 billion globally on an annual basis.  According to an updated report by CapGemini and HealthPrize Technologies, this loss is directly attributed to medication nonadherence. This persistent issue has only grown despite new healthcare stakeholder policies, programs and incentive programs…. read more

Filling the gaps in medication nonadherence

What do we know? We have long said that medication adherence is the influential lever that can lower healthcare waste, which ranges from $105 to $300 billion annually. However, without medication fill there can be no medication adherence. Studies have shown that the percentage of patients who never get their medications filled are between 28%… read more

Reining in drug cost regardless of who is president

Despite the presidential outcomes, we in the healthcare industry will still be faced with a heavy issue: how to go about reining in drug costs. Focus on adherence in real-world conditions. Our C the Cure program for a cohort of hepatitis C patients co-infected with HIV resulted in 90% of the patients having a sustained… read more

Media contact: Kristin Lindsey, Marketing Director at 866-437-8040, extension 253 or klindsey@curanthealth.com

 
EmailEmailEmailEmail
Menu Title